Find investors who align with your industry, stage, and vision. Unlock Michael Boggs’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors todayMichael Boggs is a Fund Of Funds, Venture Capital, Private Equity Firm based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Syapse, Gravie, Providence Medical Technology, Vertos Medical, Arterys, SomaLogic, Genome Medical, Nuvolo, SetPoint Medical, Evidation Health, NeuroPace. Over time, Michael Boggs has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Michael Boggs is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Asset Management, Genetics, Women Founded, Medical Testing, Enterprise Software, Women Led, Life Science, Information Services, Information Technology (IT), Analytics, Cloud Computing, Medical Device, Bioinformatics, Data Centers, Manufacturing, Healthcare, Biotechnology, Business Information Systems, Genomics, Big Data Analytics, Neuroscience, Insurance, Facility Management, Health Diagnostics, Medical, Health Insurance, SaaS, Big Data, Media and Entertainment may find it worthwhile to explore potential connections with Michael Boggs, as their portfolio suggests a familiarity and interest in this area.
Understanding Michael Boggs’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today